More articles about: Cancer Research

A research partnership has revealed a new pathway to understanding the progression of pancreatic cancer.

A new study finds AI-based diagnostic screening system, DeepGlioma, detects genetic mutations in brain tumors in under 90 seconds. Streamlining glioma diagnosis and treatment.

Protein degrader shows promise against STAT5, which plays a role in leukemia and other cancers

Russell Ryan, MD, and his team’s discovery appears to address longstanding mysteries about mutations found in B-cell acute lymphoblastic leukemia

University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.

For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?

A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma

The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.

The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.

Researchers have made strides toward targeting cancer in a new way. Through a collaboration between institutions and various scientific disciplines, scientists found a new way to attack a previously undruggable tumor suppressor.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.